Are you Dr. Xie?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 20 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5751 Hoover Blvd
Tampa, FL 33634Phone+1 813-886-8334Fax+1 813-890-0143- Is this information wrong?
Summary
- Dr. Dong Xie, MD is a board certified pathologist in Tampa, Florida. She is currently licensed to practice medicine in Florida, Tennessee, and West Virginia. She is affiliated with Tampa General Hospital and AdventHealth Tampa.
Education & Training
Ohio State University HospitalFellowship, Dermatopathology, 1998 - 1999- Ohio State University HospitalFellowship, Blood Banking/Transfusion Medicine, 1997 - 1998
- Ohio State University HospitalResidency, Pathology-Anatomic and Clinical, 1993 - 1997
Shanghai Medical UniversityClass of 1984
Certifications & Licensure
WV State Medical License 1997 - 2025
FL State Medical License 2000 - 2025
TN State Medical License 2004 - 2018- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 6 citationsAn Apparent Diffusion Coefficient Histogram Method Versus a Traditional 2-Dimensional Measurement Method for Identifying Non-Puerperal Mastitis From Breast Cancer at 3...Qi Tang, Qiang Li, Dong Xie, Ketao Chu, Lidong Liu, Chengcheng Liao, Yun-Ying Qin, Zheng Wang, Danke Su> ;Journal of Computer Assisted Tomography. 2018 Sep 1
- 10 citationsSurface modification of polyurethane with a hydrophilic, antibacterial polymer for improved antifouling and antibacterial function:Dong Xie, Leah Howard, Rashed Almousa> ;Journal of Biomaterials Applications. 2018 Aug 8
- 2 citationsA novel star-shaped poly(carboxylic acid) for resin-modified glass-ionomer restorativesYiming Weng, Leah Howard, Dong Xie> ;Journal of Biomaterials Science. Polymer Edition. 2014 Jul 2
- Join now to see all
Press Mentions
Frontier Biotechnologies' Long-Acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS PatientsOctober 27th, 2021- Frontier Biotechnologies' First Long-Acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for PatientsJuly 19th, 2021
Hospital Affiliations
Tampa General HospitalTampa, Florida
AdventHealth TampaTampa, Florida
